These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3500081)

  • 1. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA; Knothe H; Koulen G
    Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
    Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
    Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-mycoplasmal activity of a new macrolide: miocamycin.
    Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of 5 new quinolones against Gardnerella vaginalis].
    Lefevre JC; Gaubert E; Lareng MB
    Pathol Biol (Paris); 1989 May; 37(5):394-6. PubMed ID: 2550875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
    Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory and fatal activity of amoxicillin, erythromycin and josamycin against Streptococci].
    Savoia D; Angeretti A
    G Batteriol Virol Immunol; 1981; 74(7-12):283-96. PubMed ID: 7347699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
    Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
    Westerman EL; Williams TW; Moreland N
    Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis.
    Ralph ED
    Scand J Infect Dis Suppl; 1983; 40():115-20. PubMed ID: 6607518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
    Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Feb; 1(1):35-8. PubMed ID: 2656930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.